Fig. 4From: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 studyKaplan–Meier plots of progression-free survival (a) and overall survival (b) in arm N + PBack to article page